抗ZEB1抗体 (Anti-ZEB1 Antibody) | ヒト組織免疫染色用抗体
掲載日情報：2019/10/28 現在Webページ番号：15989
ZEB1に対する抗体(Anti-ZEB1 Antibody)です。
高品質なTriple A Polyclonalsブランド抗体となります。
※本製品は研究用です。研究用以外には使用できません。
カートに商品を
追加しました。
追加しました。
特長
- Atlas Antibodies社のポリクローナル抗体は「Atlas Antibodies Advanced Polyclonals」(Triple A Polyclonals)と称され、Atlas Antibodies社企業秘密のソフトウェアにより対象抗原タンパク質に対する最も適した、慎重にデザインされた抗体です。
- アフィニティーリガンドとしてリコンビナント抗原を用いた、Atlas Antibodies社独自の抗原精製過程により、特異性・信頼性・多様性が保持されています。
- 対応するリコンビナント抗原の取り扱いもあり(PrEST抗原)、ウエスタンブロット用のポジティブコントロール、および免疫組織染色での抗体ブロッキングに有用です。
- すべての抗体はHuman Protein Atlas (HPA) プロジェクトにて、様々な正常組織、腫瘍組織で検証されています。
- それぞれの抗体に対して700点以上の免疫組織染色、免疫蛍光染色、ウエスタンブロッティング像が公開されています。
Triple A Polyclonalsとは？
カートに商品を
追加しました。
追加しました。
価格
[在庫・価格 ：2025年04月26日 00時00分現在]
※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
| 詳細 | 商品名 |
|
文献数 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Anti-ZEB1, Rabbit-Poly |
|
8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[在庫・価格 ：2025年04月26日 00時00分現在]
※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
Anti-ZEB1, Rabbit-Poly
文献数： 8
- 商品コード：HPA027524
- メーカー：AAB
- 包装：100μl
- 価格：¥112,000
- 在庫：無(未発注)
- 納期：2週間程度 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。
- 法規制等：
| 説明文 | バリデーション情報：ORTHOGONAL, STANDARD 別名：AREB6，BZP，FECD6，NIL-2-A，PPCD3，TCF8，ZEB，Zfhep，Zfhx1a Genbank No： 6935 Protein Accession No： P37275 |
||||||
|---|---|---|---|---|---|---|---|
| 別包装品 | 別包装品あり | ||||||
| 法規制等 | |||||||
| 保存条件 | -20℃ | 法規備考 | |||||
| 抗原種 | Human | 免疫動物 | Rabbit | ||||
| 交差性 | Human | 適用 | ChIP,ChIP-exo-seq,ChIP-seq,IC,IHC | ||||
| 標識 | Unlabeled | 性状 | Antigen Affinity Purified | ||||
| 吸収処理 | クラス | IgG | |||||
| クロナリティ | Polyclonal | フォーマット | |||||
| 掲載カタログ |
|
||||||
| 製品記事 | |||||||
| 関連記事 | |||||||
カートに商品を
追加しました。
追加しました。
製品情報
免疫組織染色(IHC)  | Immunohistochemical staining of human liver shows no nuclear positivity in hepatocytes as expected. 推奨プロトコル(Recommended conditions) |
免疫蛍光染色(IF)  | Immunofluorescent staining of human cell line U-2 OS shows localization to nucleoplasm. Antibody staining is shown in green. 推奨プロトコル(Recommended conditions) |
関連データベース(Database Links)
抗原情報(Antigen Sequence)
Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence: : EAEKPESSVSSATGDGNLSPSQPPLKNLLSLLKAYYALNAQPSAEELSKIADSVNLPLDVVKKWFEKMQAGQISVQSSEPSSPEPGKVNIPAKNNDQPQSANANEPQDSTVNLQSPLKMTNSPVLPVGST
抗体の精製方法(Purification Method)
Affinity purified using the PrEST antigen as affinity ligand
ホモロジー情報(Interspecies Information)
性状(Form)
40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
保存方法(Storage)
Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Notes
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user.
References
Title
ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming
Source
J Clin Invest
Mishra P, Tang W, Putluri V, Dorsey TH, Jin F, Wang F, Zhu D, Amable L, Deng T, Zhang S, Killian JK, Wang Y, Minas TZ, Yfantis HG, Lee DH, Sreekumar A, Bustin M, Liu W, Putluri N, Ambs S.
ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming
Source
J Clin Invest
Mishra P, Tang W, Putluri V, Dorsey TH, Jin F, Wang F, Zhu D, Amable L, Deng T, Zhang S, Killian JK, Wang Y, Minas TZ, Yfantis HG, Lee DH, Sreekumar A, Bustin M, Liu W, Putluri N, Ambs S.
Title
Distinguishing mechanisms underlying EMT tristability
Source
Cancer Converg
Jia D, Jolly MK, Tripathi SC, Den Hollander P, Huang B, Lu M, Celiktas M, Ramirez-Peña E, Ben-Jacob E, Onuchic JN, Hanash SM, Mani SA, Levine H.
Distinguishing mechanisms underlying EMT tristability
Source
Cancer Converg
Jia D, Jolly MK, Tripathi SC, Den Hollander P, Huang B, Lu M, Celiktas M, Ramirez-Peña E, Ben-Jacob E, Onuchic JN, Hanash SM, Mani SA, Levine H.
Title
Phytosphingosine exhibits an anti-epithelial–mesenchymal transition function by the inhibition of EGFR signaling in human breast cancer cells
Source
Oncotarget
Kang HM, Son HS, Cui YH, Youn B, Son B, Kaushik NK, Uddin N, Lee JS, Song JY, Kaushik N, Lee SJ.
Phytosphingosine exhibits an anti-epithelial–mesenchymal transition function by the inhibition of EGFR signaling in human breast cancer cells
Source
Oncotarget
Kang HM, Son HS, Cui YH, Youn B, Son B, Kaushik NK, Uddin N, Lee JS, Song JY, Kaushik N, Lee SJ.
Title
Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma
Source
PLoS One
Euskirchen P, Radke J, Schmidt MS, Schulze Heuling E, Kadikowski E, Maricos M, Knab F, Grittner U, Zerbe N, Czabanka M, Dieterich C, Miletic H, Mørk S, Koch A, Endres M, Harms C.
Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma
Source
PLoS One
Euskirchen P, Radke J, Schmidt MS, Schulze Heuling E, Kadikowski E, Maricos M, Knab F, Grittner U, Zerbe N, Czabanka M, Dieterich C, Miletic H, Mørk S, Koch A, Endres M, Harms C.
Title
Loss of DIP2C in RKO cells stimulates changes in DNA methylation and epithelial-mesenchymal transition
Source
BMC Cancer
Larsson C, Ali MA, Pandzic T, Lindroth AM, He L, Sjöblom T.
Loss of DIP2C in RKO cells stimulates changes in DNA methylation and epithelial-mesenchymal transition
Source
BMC Cancer
Larsson C, Ali MA, Pandzic T, Lindroth AM, He L, Sjöblom T.
Title
Succession of transiently active tumor‐initiating cell clones in human pancreatic cancer xenografts
Source
EMBO Mol Med
Ball CR, Oppel F, Ehrenberg KR, Dubash TD, Dieter SM, Hoffmann CM, Abel U, Herbst F, Koch M, Werner J, Bergmann F, Ishaque N, Schmidt M, von Kalle C, Scholl C, Fröhling S, Brors B, Weichert W, Weitz J, Glimm H.
Succession of transiently active tumor‐initiating cell clones in human pancreatic cancer xenografts
Source
EMBO Mol Med
Ball CR, Oppel F, Ehrenberg KR, Dubash TD, Dieter SM, Hoffmann CM, Abel U, Herbst F, Koch M, Werner J, Bergmann F, Ishaque N, Schmidt M, von Kalle C, Scholl C, Fröhling S, Brors B, Weichert W, Weitz J, Glimm H.
Title
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
Source
Nature Cell Biology
Angela M. Krebs, Julia Mitschke, María Lasierra Losada, Otto Schmalhofer, Melanie Boerries, Hauke Busch, Martin Boettcher, Dimitrios Mougiakakos, Wilfried Reichardt, Peter Bronsert, Valerie G. Brunton, Christian Pilarsky, Thomas H. Winkler, Simone Brabletz, Marc P. Stemmler, Thomas Brabletz.
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
Source
Nature Cell Biology
Angela M. Krebs, Julia Mitschke, María Lasierra Losada, Otto Schmalhofer, Melanie Boerries, Hauke Busch, Martin Boettcher, Dimitrios Mougiakakos, Wilfried Reichardt, Peter Bronsert, Valerie G. Brunton, Christian Pilarsky, Thomas H. Winkler, Simone Brabletz, Marc P. Stemmler, Thomas Brabletz.
Title
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer
Source
Oncotarget
Preca BT, Bajdak K, Mock K, Lehmann W, Sundararajan V, Bronsert P, Matzge-Ogi A, Orian-Rousseau V, Brabletz S, Brabletz T, Maurer J, Stemmler MP.
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer
Source
Oncotarget
Preca BT, Bajdak K, Mock K, Lehmann W, Sundararajan V, Bronsert P, Matzge-Ogi A, Orian-Rousseau V, Brabletz S, Brabletz T, Maurer J, Stemmler MP.
Title
Resetting cancer stem cell regulatory nodes upon MYC inhibition
Source
EMBO Rep
Galardi S, Savino M, Scagnoli F, Pellegatta S, Pisati F, Zambelli F, Illi B, Annibali D, Beji S, Orecchini E, Alberelli MA, Apicella C, Fontanella RA, Michienzi A, Finocchiaro G, Farace MG, Pavesi G, Ciafrè SA, Nasi S.
Resetting cancer stem cell regulatory nodes upon MYC inhibition
Source
EMBO Rep
Galardi S, Savino M, Scagnoli F, Pellegatta S, Pisati F, Zambelli F, Illi B, Annibali D, Beji S, Orecchini E, Alberelli MA, Apicella C, Fontanella RA, Michienzi A, Finocchiaro G, Farace MG, Pavesi G, Ciafrè SA, Nasi S.
Title
Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells
Source
Oncotarget
Koch K, Hartmann R, Schröter F, Suwala AK, Maciaczyk D, Krüger AC, Willbold D, Kahlert UD, Maciaczyk J.
Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells
Source
Oncotarget
Koch K, Hartmann R, Schröter F, Suwala AK, Maciaczyk D, Krüger AC, Willbold D, Kahlert UD, Maciaczyk J.
Title
Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer
Source
Oncotarget
Kim RK, Kaushik N, Suh Y, Yoo KC, Cui YH, Kim MJ, Lee HJ, Kim IG, Lee SJ.
Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer
Source
Oncotarget
Kim RK, Kaushik N, Suh Y, Yoo KC, Cui YH, Kim MJ, Lee HJ, Kim IG, Lee SJ.
Title
Loss of zfp36 expression in colorectal cancer correlates to wnt/ β-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of zeb1, sox9 and macc1
Source
Oncotarget
Montorsi L, Guizzetti F, Alecci C, Caporali A, Martello A, Atene CG, Parenti S, Pizzini S, Zanovello P, Bortoluzzi S, Ferrari S, Grande A, Zanocco-Marani T.
Loss of zfp36 expression in colorectal cancer correlates to wnt/ β-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of zeb1, sox9 and macc1
Source
Oncotarget
Montorsi L, Guizzetti F, Alecci C, Caporali A, Martello A, Atene CG, Parenti S, Pizzini S, Zanovello P, Bortoluzzi S, Ferrari S, Grande A, Zanocco-Marani T.
Title
TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype
Source
EMBO Mol Med
Fessler E, Drost J, van Hooff SR, Linnekamp JF, Wang X, Jansen M, De Sousa E Melo F, Prasetyanti PR, IJspeert JE, Franitza M, Nürnberg P, van Noesel CJ, Dekker E, Vermeulen L, Clevers H, Medema JP.
TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype
Source
EMBO Mol Med
Fessler E, Drost J, van Hooff SR, Linnekamp JF, Wang X, Jansen M, De Sousa E Melo F, Prasetyanti PR, IJspeert JE, Franitza M, Nürnberg P, van Noesel CJ, Dekker E, Vermeulen L, Clevers H, Medema JP.
Title
Zeb1 controls neuron differentiation and germinal zone exit by a mesenchymal-epithelial-like transition
Source
eLife
Singh S, Howell D, Trivedi N, Kessler K, Ong T, Rosmaninho P, Raposo AA, Robinson G, Roussel MF, Castro DS, Solecki DJ.
Zeb1 controls neuron differentiation and germinal zone exit by a mesenchymal-epithelial-like transition
Source
eLife
Singh S, Howell D, Trivedi N, Kessler K, Ong T, Rosmaninho P, Raposo AA, Robinson G, Roussel MF, Castro DS, Solecki DJ.
Title
ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types
Source
Nat Commun
Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, Herr R, Brabletz S, Stemmler MP, Brabletz T.
ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types
Source
Nat Commun
Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, Herr R, Brabletz S, Stemmler MP, Brabletz T.
Title
Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach
Source
Cell Death Dis
Flanagan L, Meyer M, Fay J, Curry S, Bacon O, Duessmann H, John K, Boland KC, McNamara DA, Kay EW, Bantel H, Schulze-Bergkamen H, Prehn JH.
Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach
Source
Cell Death Dis
Flanagan L, Meyer M, Fay J, Curry S, Bacon O, Duessmann H, John K, Boland KC, McNamara DA, Kay EW, Bantel H, Schulze-Bergkamen H, Prehn JH.
Title
Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial–mesenchymal transition phenotype
Source
Laboratory Investigation
Yuji Sakuma, Hirotaka Nishikiori, Sachie Hirai, Miki Yamaguchi, Gen Yamada, Atsushi Watanabe, Tadashi Hasegawa, Takashi Kojima, Toshiro Niki, Hiroki Takahashi.
Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial–mesenchymal transition phenotype
Source
Laboratory Investigation
Yuji Sakuma, Hirotaka Nishikiori, Sachie Hirai, Miki Yamaguchi, Gen Yamada, Atsushi Watanabe, Tadashi Hasegawa, Takashi Kojima, Toshiro Niki, Hiroki Takahashi.
Title
Expression of zinc finger E-box-binding homeobox factor 1 in epithelial ovarian cancer: A clinicopathological analysis of 238 patients
Source
Mol Clin Oncol
LI X, HUANG R, LI RH, TROPE CG, NESLAND JM, SUO Z.
Expression of zinc finger E-box-binding homeobox factor 1 in epithelial ovarian cancer: A clinicopathological analysis of 238 patients
Source
Mol Clin Oncol
LI X, HUANG R, LI RH, TROPE CG, NESLAND JM, SUO Z.
Title
SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150
Source
Oncogene
A Barbáchano, A Fernández-Barral, F Pereira, M F Segura, P Ordóñez-Morán, E Carrillo-de Santa Pau, J M González-Sancho, D Hanniford, N Martínez, A Costales-Carrera, F X Real, H G Pálmer, J M Rojas, E Hernando, A Muñoz.
SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150
Source
Oncogene
A Barbáchano, A Fernández-Barral, F Pereira, M F Segura, P Ordóñez-Morán, E Carrillo-de Santa Pau, J M González-Sancho, D Hanniford, N Martínez, A Costales-Carrera, F X Real, H G Pálmer, J M Rojas, E Hernando, A Muñoz.
Title
EMT-associated factors promote invasive properties of uveal melanoma cells
Source
Mol Vis
Asnaghi L, Gezgin G, Tripathy A, Handa JT, Merbs SL, van der Velden PA, Jager MJ, Harbour JW, Eberhart CG.
EMT-associated factors promote invasive properties of uveal melanoma cells
Source
Mol Vis
Asnaghi L, Gezgin G, Tripathy A, Handa JT, Merbs SL, van der Velden PA, Jager MJ, Harbour JW, Eberhart CG.
Title
The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors
Source
Oncotarget
Mock K, Preca BT, Brummer T, Brabletz S, Stemmler MP, Brabletz T.
The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors
Source
Oncotarget
Mock K, Preca BT, Brummer T, Brabletz S, Stemmler MP, Brabletz T.
Title
ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
Source
EMBO Mol Med
Meidhof S, Brabletz S, Lehmann W, Preca BT, Mock K, Ruh M, Schüler J, Berthold M, Weber A, Burk U, Lübbert M, Puhr M, Culig Z, Wellner U, Keck T, Bronsert P, Küsters S, Hopt UT, Stemmler MP, Brabletz T.
ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
Source
EMBO Mol Med
Meidhof S, Brabletz S, Lehmann W, Preca BT, Mock K, Ruh M, Schüler J, Berthold M, Weber A, Burk U, Lübbert M, Puhr M, Culig Z, Wellner U, Keck T, Bronsert P, Küsters S, Hopt UT, Stemmler MP, Brabletz T.
Title
Stromal contribution to the colorectal cancer transcriptome
Source
Nature Genetics
Claudio Isella, Andrea Terrasi, Sara Erika Bellomo, Consalvo Petti, Giovanni Galatola, Andrea Muratore, Alfredo Mellano, Rebecca Senetta, Adele Cassenti, Cristina Sonetto, Giorgio Inghirami, Livio Trusolino, Zsolt Fekete, Mark De Ridder, Paola Cassoni, Guy Storme, Andrea Bertotti, Enzo Medico.
Stromal contribution to the colorectal cancer transcriptome
Source
Nature Genetics
Claudio Isella, Andrea Terrasi, Sara Erika Bellomo, Consalvo Petti, Giovanni Galatola, Andrea Muratore, Alfredo Mellano, Rebecca Senetta, Adele Cassenti, Cristina Sonetto, Giorgio Inghirami, Livio Trusolino, Zsolt Fekete, Mark De Ridder, Paola Cassoni, Guy Storme, Andrea Bertotti, Enzo Medico.
Title
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.
Source
Hum Pathol
Davidson B, Holth A, Hellesylt E, Tan TZ, Huang RY, Tropé C, Nesland JM, Thiery JP.
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.
Source
Hum Pathol
Davidson B, Holth A, Hellesylt E, Tan TZ, Huang RY, Tropé C, Nesland JM, Thiery JP.
Title
CD95 and CD95L promote and protect cancer stem cells
Source
Nat Commun
Ceppi P, Hadji A, Kohlhapp FJ, Pattanayak A, Hau A, Liu X, Liu H, Murmann AE, Peter ME.
CD95 and CD95L promote and protect cancer stem cells
Source
Nat Commun
Ceppi P, Hadji A, Kohlhapp FJ, Pattanayak A, Hau A, Liu X, Liu H, Murmann AE, Peter ME.
Title
Epithelial-Mesenchymal Transition Induces Endoplasmic-Reticulum-Stress Response in Human Colorectal Tumor Cells
Source
PLoS One
Zeindl-Eberhart E, Brandl L, Liebmann S, Ormanns S, Scheel SK, Brabletz T, Kirchner T, Jung A.
Epithelial-Mesenchymal Transition Induces Endoplasmic-Reticulum-Stress Response in Human Colorectal Tumor Cells
Source
PLoS One
Zeindl-Eberhart E, Brandl L, Liebmann S, Ormanns S, Scheel SK, Brabletz T, Kirchner T, Jung A.
Title
Direct RNA sequencing mediated identification of mRNA localized in protrusions of human MDA-MB-231 metastatic breast cancer cells
Source
J Mol Signal
Jakobsen KR, Sørensen E, Brøndum KK, Daugaard TF, Thomsen R, Nielsen AL.
Direct RNA sequencing mediated identification of mRNA localized in protrusions of human MDA-MB-231 metastatic breast cancer cells
Source
J Mol Signal
Jakobsen KR, Sørensen E, Brøndum KK, Daugaard TF, Thomsen R, Nielsen AL.
Title
Dual Roles of the Transcription Factor Grainyhead-like 2 (GRHL2) in Breast Cancer
Source
J Biol Chem
Werner S, Frey S, Riethdorf S, Schulze C, Alawi M, Kling L, Vafaizadeh V, Sauter G, Terracciano L, Schumacher U, Pantel K, Assmann V.
Dual Roles of the Transcription Factor Grainyhead-like 2 (GRHL2) in Breast Cancer
Source
J Biol Chem
Werner S, Frey S, Riethdorf S, Schulze C, Alawi M, Kling L, Vafaizadeh V, Sauter G, Terracciano L, Schumacher U, Pantel K, Assmann V.
Title
The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells
Source
Int J Oncol
PACURARI M, ADDISON JB, BONDALAPATI N, WAN YW, LUO D, QIAN Y, CASTRANOVA V, IVANOV AV, GUO NL.
The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells
Source
Int J Oncol
PACURARI M, ADDISON JB, BONDALAPATI N, WAN YW, LUO D, QIAN Y, CASTRANOVA V, IVANOV AV, GUO NL.
Title
Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation
Source
Cell Cycle
Pieraccioli M, Imbastari F, Antonov A, Melino G, Raschellà G.
Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation
Source
Cell Cycle
Pieraccioli M, Imbastari F, Antonov A, Melino G, Raschellà G.
Title
Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer
Source
PLoS One
Roca H, Hernandez J, Weidner S, McEachin RC, Fuller D, Sud S, Schumann T, Wilkinson JE, Zaslavsky A, Li H, Maher CA, Daignault-Newton S, Healy PN, Pienta KJ.
Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer
Source
PLoS One
Roca H, Hernandez J, Weidner S, McEachin RC, Fuller D, Sud S, Schumann T, Wilkinson JE, Zaslavsky A, Li H, Maher CA, Daignault-Newton S, Healy PN, Pienta KJ.
Title
Epithelial to Mesenchymal Transition in Murine Tracheal Allotransplantation: An Immunohistochemical Observation
Source
Transplant Proc
Konoeda C, Koinuma D, Morishita Y, Sano A, Nagayama K, Motomura N, Kakimi K, Miyazono K, Nakajima J, Nicolls MR, Murakawa T.
Epithelial to Mesenchymal Transition in Murine Tracheal Allotransplantation: An Immunohistochemical Observation
Source
Transplant Proc
Konoeda C, Koinuma D, Morishita Y, Sano A, Nagayama K, Motomura N, Kakimi K, Miyazono K, Nakajima J, Nicolls MR, Murakawa T.
Title
Zeb1 Regulates E-cadherin and Epcam (Epithelial Cell Adhesion Molecule) Expression to Control Cell Behavior in Early Zebrafish Development
Source
J Biol Chem
Vannier C, Mock K, Brabletz T, Driever W.
Zeb1 Regulates E-cadherin and Epcam (Epithelial Cell Adhesion Molecule) Expression to Control Cell Behavior in Early Zebrafish Development
Source
J Biol Chem
Vannier C, Mock K, Brabletz T, Driever W.
Title
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions.
Source
Nat Med
De Sousa E Melo F, Wang X, Jansen M, Fessler E, Trinh A, de Rooij LP, de Jong JH, de Boer OJ, van Leersum R, Bijlsma MF, Rodermond H, van der Heijden M, van Noesel CJ, Tuynman JB, Dekker E, Markowetz F, Medema JP, Vermeulen L.
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions.
Source
Nat Med
De Sousa E Melo F, Wang X, Jansen M, Fessler E, Trinh A, de Rooij LP, de Jong JH, de Boer OJ, van Leersum R, Bijlsma MF, Rodermond H, van der Heijden M, van Noesel CJ, Tuynman JB, Dekker E, Markowetz F, Medema JP, Vermeulen L.
Title
Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma.
Source
Mol Cell Biochem
Jia B, Liu H, Kong Q, Li B.
Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma.
Source
Mol Cell Biochem
Jia B, Liu H, Kong Q, Li B.
Title
Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization
Source
Biotechniques
Hanna JA, Wimberly H, Kumar S, Slack F, Agarwal S, Rimm DL.
Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization
Source
Biotechniques
Hanna JA, Wimberly H, Kumar S, Slack F, Agarwal S, Rimm DL.
Title
The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5
Source
Oncotarget
Sundararajan V, Gengenbacher N, Stemmler MP, Kleemann JA, Brabletz T, Brabletz S.
The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5
Source
Oncotarget
Sundararajan V, Gengenbacher N, Stemmler MP, Kleemann JA, Brabletz T, Brabletz S.
カートに商品を
追加しました。
追加しました。
抗原情報(Antigen Sequence)
Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence: : EAEKPESSVSSATGDGNLSPSQPPLKNLLSLLKAYYALNAQPSAEELSKIADSVNLPLDVVKKWFEKMQAGQISVQSSEPSSPEPGKVNIPAKNNDQPQSANANEPQDSTVNLQSPLKMTNSPVLPVGST[在庫・価格 ：2025年04月26日 00時00分現在]
※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
| 詳細 | 商品名 |
|
文献数 | ||
|---|---|---|---|---|---|
|
PrEST Antigen ZEB1, Human, Recombinant |
|
0 | |||
[在庫・価格 ：2025年04月26日 00時00分現在]
※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
PrEST Antigen ZEB1, Human, Recombinant
文献数： 0
- 商品コード：APrEST84772
- メーカー：AAB
- 包装：100μl
- 価格：¥65,000
- 在庫：無(未発注)
- 納期：ご照会下さい ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。
- 法規制等：
カートに商品を
追加しました。
追加しました。
関連製品情報
高性能な免疫組織染色用の抗原賦活化装置： 「Decloaking Chamber NxGen」 ⇒ 詳細はこちら
カートに商品を
追加しました。
追加しました。
製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。